Takeda Pharmaceutical Co said on Wednesday it was developing a drug for high-risk patients infected with the new coronavirus, joining several other drugmakers seeking to develop a treatment for an illness that has killed over 3,000 people. The Japanese firm said it was working on a plasma-derived therapy which had previously been shown to be
Forty-five people will be enrolled in the preliminary safety trial of the new vaccine. Researchers in Seattle have begun recruiting healthy volunteers to participate in a clinical trial for an experimental COVID-19 vaccine, according to news reports. The vaccine, developed by the biotechnology company Moderna Therapeutics, was initially sent to the National Institute of Allergy
Genetic data show that a Brasilian case, looking to be connected with Italy, could be tracked down to Germany and China. Source MIT Technology Review In the unprecedented outbreak of a new coronavirus sweeping the world, the germ’s genetic material may ultimately tell the story not just of where it came from, but of how
A 33-year-old German man may be the first European to have contracted the infection of the new coronavirus and to have transmitted it. This was reported by a letter from German doctors published in the New England Journal of Medicine on March 5. The man experienced respiratory symptoms and high fever on January 24th. The
The coronavirus has evolved into two major types, with differing transmission rates and geographical distribution, according to a study published in the National Science Review yesterday. A group of Chinese scientists analysed 103 coronavirus genomes and identified mutations in 149 sites across the strains. They found that one type, which they called the L type, was more
The head of the World Health Organization said on Tuesday that the global mortality rate for Covid-19, the disease caused by the new coronavirus, was 3.4 percent. Tedros Adhanom Ghebreyesus, the organization’s director general, said in a news conference in Geneva that Covid-19 is deadlier than the seasonal flu, but does not transmit as easily.
source NIH Director The recent COVID-19 outbreak of a novel type of coronavirus that began in China has prompted a massive global effort to contain and slow its spread. Despite those efforts, over the last month the virus has begun circulating outside of China in multiple countries and territories. Cases have now appeared in the
The structure was solved by a team including the University of Chicago (U of C), the U.S. Department of Energy’s (DOE) Argonne National Laboratory, Northwestern University Feinberg School of Medicine and the University of California, Riverside School of Medicine (UCR). Drugs previously in development for SARS could be effective for COVID-19 A potential drug target
The number of cases in China continues to decline. Yesterday, China reported 206 cases of COVID-19 to WHO, the lowest since the 22nd of January. Only 8 cases were reported outside Hubei province yesterday. Outside China, a total of 8739 cases of COVID-19 have been reported to WHO from 61 countries, with 127 deaths. In the
The emergence and rapid increase in cases of coronavirus disease 2019 (COVID-19), a respiratory illness caused by a novel coronavirus, pose complex challenges to the global public health, research and medical communities, write federal scientists from NIH’s National Institute of Allergy and Infectious Diseases (NIAID) and from the Centers for Disease Control and Prevention (CDC).
